1. Introduction {#s0005}
===============

Neuroimaging has played an important role in understanding the neurobiological basis of many neurodevelopmental and psychiatric disorders. The majority of these studies have examined brain differences at a group level, often comparing a population of interest to a healthy or psychiatric control population. These studies are informative for identifying patterns of brain differences associated with a particular group or disorder; however, the assumption that the pathology of these disorders are consistent across all individuals with the disorder is inherently implied and implausible ([@bb0310]). While general morphological, organizational, and functional features of the brain are conserved during typical development within our species, and consistency of brain differences between individuals with developmental neuropsychiatric disorders and other groups may exist, the human brain is remarkably variable across individuals ([@bb0205], [@bb0305], [@bb0355], [@bb0455], [@bb0495], [@bb0650]), suggesting that patterns of individual brain differences may help elucidate the neural mechanisms involved. This may be especially likely in clinically multifaceted, etiologically heterogeneous neurodevelopmental disorders, such as autism spectrum disorder (ASD), which emerges and is sustained in the midst of a complex cascade of interacting biological events and life experiences.

ASD results from atypical brain development and is clinically recognized by clustering, within affected individuals, of behaviors indicating abnormal development of reciprocal social interaction and social communication and unusual patterns of highly restricted and repetitive behaviors and interests ([@bb0030]). The term "spectrum" reflects that it is not yet possible to reliably distinguish or validate clinically meaningful subcategories of ASD at the clinical, biomarker, or neuroimaging level. In addition, ASD presents with a wide range of diverse symptom that may vary in severity ([@bb0210]), frequent association with a variety of co-occurring neuropsychiatric and medical conditions, some symptom overlap with other disorders ([@bb0265], [@bb0565], [@bb0630]) and variable (but typically early) age of onset across diagnosed individuals ([@bb0475], [@bb0595]). Though the prevalence of the disorder has recently been estimated to affect 1 in 68 children ([@bb0110]), some children begin to show delays within the first 12 months of life, while others (25%--40%) regress from typical development to autism-like behaviors between 12 and 24 months ([@bb0595]). Moreover, individual phenotypes of ASD are likely influenced by complex gene-environment interactions. For instance, many genes of small effect are heritable and contribute to the observable characteristics of ASD, while these characteristics are further modulated by one\'s environment via epigenetic mechanisms ([@bb0005], [@bb0275]).

The heterogeneity of the autism phenotype has similarly made the interpretation of brain imaging studies examining the neurobiological basis of ASD challenging. Magnetic resonance imaging (MRI) studies have suggested that the pathogenesis of autism involves alterations to brain volume ([@bb0140], [@bb0250], [@bb0425], [@bb0480]), as well as widespread region-specific differences across the brain, involving the cerebellum, amygdala, and thalamus ([@bb0240], [@bb0250], [@bb0460], [@bb0510]), among others (for review, see ([@bb0020], [@bb0040], [@bb0190], [@bb0330], [@bb0575])). Similarly, diffusion tensor imaging (DTI) studies have further revealed differences across white matter microstructure (for review, see ([@bb0545])), while other imaging strategies have associated ASD with alterations of cortical thickness ([@bb0255], [@bb0585], [@bb0645]) and brain connectivity ([@bb0045], [@bb0075], [@bb0300], [@bb0315], [@bb0580]). Furthermore, group differences have been observed to be dynamic, as recent studies have highlighted disparities of developmental trajectories between individuals with and without autism ([@bb0255], [@bb0360], [@bb0560], [@bb0600], [@bb0605], [@bb0645]).

Despite a growing body of literature showing significant group differences across an assortment of neuroimaging techniques, there has been poor replication across studies of autism, while many of these studies report greater neuroanatomical variability across the ASD group ([@bb0020], [@bb0040], [@bb0095], [@bb0230], [@bb0245], [@bb0440], [@bb0545]). While this variability may stem from the variation of study populations or different analytical techniques, it is clear from the range of findings that the neuroanatomy of ASD, as its behavioral counterpart, is not restricted to a single brain region, specific network or even a common biological mechanism. Instead, these differences appear to be subtle and widespread ([@bb0185]), and these differences potentially vary from person-to-person. Being able to characterize each person with ASD based on the degree of how the multidimensional measures of his/her brain differ from the general population would provide a method to numerically represent the degree of brain abnormality in each individual. Thus, there is a critical need to better characterize the distributions of these previous measures on the individual level in order to advance the clinical utility of brain imaging findings in autism.

The extent to which multivariate brain relationships may enable better characterization and discrimination at the individual level, as compared to commonly utilized univariate measures, remains unclear. Distinguishing such relationships, however, is critical as a multivariate description could be informative for identifying phenotypical subgroups, better understanding individual brain changes, and guiding personalized therapies or interventions ([@bb0090], [@bb0325], [@bb0390]). Multivariate analysis techniques, which seek to evaluate multiple measures simultaneously, have great potential to discern underlying relationships in a wide variety of neuroimaging applications, including assessment of clinical outcomes and diagnosis, characterizing disease etiology and progression, as well as evaluating neurodevelopmental and neurodegenerative diseases ([@bb0225], [@bb0380], [@bb0430]). While a wide variety of multivariate strategies exist, one such multivariate measure which is an extension of the Euclidean distance, known as the Mahalanobis distance (D~M~; ([@bb0415])), may be informative for distinguishing such multivariate brain relationships. D~M~ has been applied and shown to be informative in various neuroimaging contexts, including signal outlier detection ([@bb0200]), differentiating brain tissue types ([@bb0535]), classifying neurological diseases ([@bb0100], [@bb0395]), and evaluating relationships of development ([@bb0320]) and connectivity ([@bb0520]). Hence, D~M~ may be advantageous to detect individual brain differences in neurodevelopmental disorders, such as ASD, however, this remains unapproached.

In this study, we utilize D~M~ to characterize individual brain differences in a large, longitudinal sample of individuals with and without ASD. Specifically, we describe a framework which to measure D~M~ from this longitudinal cohort and investigate whether multivariate white matter microstructural features distinguish individuals with ASD from their typically developing peers. We further examine the degree to which microstructural characteristics are associated with measures of autism symptom severity.

2. Materials and methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

The institutional review boards of the University of Utah and University of Wisconsin-Madison approved the study protocol and procedures. Participants consisted of 92 individuals with ASD and 57 typically developing controls (TDC), selected from a broader longitudinal study of brain development in autism and typical development ([@bb0360], [@bb0560], [@bb0550], [@bb0555], [@bb0645]). Consent was obtained from all adult participants, and both parental consent and participant assent were obtained for participants under the age of 18 years. Exclusion criteria consisted of: history of severe head injury, seizure disorder, hypoxia-ischemia, genetic disorder associated with ASD (identified with Fragile-X testing or karyotype), known medical cause of ASD diagnosis (e.g. known patient history, and physical exam), and/or other neurological disorders. All participants were male and ranged in age from 3.3 and 36.8 years at the time of enrollment. Participants were recruited and clinically assessed; they underwent MRI scanning one to four times as part of an accelerated longitudinal study design over an approximately 10-year period ([@bb2000]; see [Fig. 1](#f0005){ref-type="fig"}). Fifty-seven participants had four scans (42 ASD and 15 TDC), 32 participants had three scans (18 ASD and 14 TDC), 37 participants had two scans (18 ASD and 19 TDC), and 23 participants had one scan (14 ASD and 9 TDC). The average interval between scans was 2.6 years. See [Table 1](#t0005){ref-type="table"} for additional participant information.Fig. 1Longitudinal sampling of ASD and TDC participants. Ages of the 149 subjects at each scan. The age of each subject at each time point is denoted along each row and the repeated measurements are connected with a solid line. Individuals diagnosed with ASD (red) and TDC (blue) are additionally distinguished. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 1Table 1Demographic characteristics of the longitudinal ASD and TDC groups.Table 1ASDTDCp-ValueNumber of subjects9257--Mean age (years)18.15 (8.47)19.16 (7.95)0.23Mean scans per subject (Std. dev)2.96 (1.13)2.61 (1.05)0.06Mean inter-scan interval (Std. dev) \[years\]2.82 (0.83)2.77 (1.02)0.69Total number of scans272149--Number of scans at time 19257--Number of scans at time 27848--Number of scans at time 36029--Number of scans at time 44215--Mean FSIQ (Std. dev)99.42 (17.70)118.17 (13.23)\< 0.001Mean PIQ (Std. dev)102.24 (18.10)116.34 (14.76)\< 0.001Mean VIQ (Std. dev)95.06 (21.63)114.72 (13.21)\< 0.001Mean total raw SRS (Std. dev)99.73 (30.30)15.57 (11.79)\< 0.001

Participants with ASD were diagnosed according to the Autism Diagnostic Interview-Revised (ADI-R; ([@bb0410])), Autism Diagnostic Observation Schedule-Generic (ADOS-G; ([@bb0405])), Diagnostic Statistical Manual-IV ([@bb0035]), and the International Statistical Classification of Diseases and Related Health Problems-10th revision (ICD-10) criteria ([@bb0620]). Typical development was confirmed by performing standardized psychiatric assessment, neuropsychological assessment, IQ testing and assessment with the ADOS-G ([@bb0405]). All ASD and TDC participants received IQ testing at each time point, providing indices of verbal (VIQ), performance (PIQ) and full-scale (FSIQ) IQ. The Social Responsiveness Scale (SRS; [@bb3000]), a standardized parent-report questionnaire that assesses the degree of ASD symptom severity, was additionally completed; however, as the age range of the present study extended beyond the normed age range for the SRS (4--18 years), total raw scores are reported. Individuals with less socially reciprocal behavior are indicated by higher total raw SRS scores.

2.2. Imaging protocol {#s0020}
---------------------

A total of 421 scans were acquired from the participants (272 ASD, 149 TDC). All magnetic resonance images were collected on a Siemens Tim Trio 3.0 T scanner at the University of Utah. At each time point, diffusion-weighted imaging (DWI) data were obtained using a single shot spin-echo echo-planar imaging pulse sequence. Bipolar gradients with dual-echo refocusing was used to reduce eddy currents ([@bb0500]), while parallel acquisition, with a geometric reduction factor of two, was used to reduce image distortions from magnetic field inhomogeneities and acquisition time. Imaging parameters consisted of: repetition time: 7000 ms; echo time: 84 ms at time 1, and 91 ms at times 2, 3, 4; and bandwidth: 1346 Hz/pixel. A 25.6 cm × 25.6 cm imaging field of view was used in conjunction with an acquisition matrix of 128 × 128 to provide a 2 mm × 2 mm in-plane resolution. Coverage across the cerebrum and cerebellum was achieved by acquiring 60 axial-oriented contiguous slices with a slice thickness of 2.5 mm. Diffusion data were acquired with diffusion encoded along 12 non-collinear directions with b = 1000s/mm^2^ and a single non-diffusion weighted (b = 0 s/mm^2^) image. The acquisition was averaged across four repeats for a total imaging time of 6.5 min.

To improve prospects of successful DTI acquisition, participants were able to practice lying in a mock MRI scanner. Sedation was offered to young participants with ASD, using a combination of remifentanil and propofol, if needed to improve data quality. In total, 47 of the 434 longitudinal scans were acquired under a strict clinical sedation protocol approved by the University of Utah\'s Institutional Review Board and that was performed and monitored by an onsite faculty anesthesiologist. A total motion index (TMI) was recorded to account for the effects of potential group differences in head motion during MRI scanning ([@bb0080], [@bb0625]) and used in later analyses. Between times 1 and 2, the scanner hardware and software underwent an upgrade, resulting in a head coil change (8-channel receive-only coil at time 1 and a 12-channel receive-only coil at times 2, 3, 4) and alteration of the DWI echo time (described above), however, there was no significant group difference of the proportion of scans prior to and following the scanner upgrade (Z = − 0.51; p = 0.61).

2.3. Image analysis {#s0025}
-------------------

All image processing and analyses were conducted at the University of Wisconsin-Madison and were processed using methods previously described ([@bb0560]). Individual diffusion weighted images were co-registered to account for any subtle distortion, translation and rotation from bulk head motion and eddy currents using an affine registration tool ([@bb0270]) from the FMRIB software library (FSL; <http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/>) suite, while gradient directions were corrected for rotations ([@bb0375]). FSL\'s brain extraction tool (BET; ([@bb0525])) was used to remove non-parenchyma signals. Diffusion tensors were fit at each voxel using the robust estimation of tensors by outlier rejection (RESTORE; ([@bb0115])) algorithm as part of the Camino software package ([@bb0125]). Eigenvalues (λ~1~, λ~2~, λ~3~) were calculated from these voxel-wise estimates of the diffusion tensor and quantitative maps of fractional anisotropy (FA -- normalized standard deviation of the eigenvalues reflecting the relative degree of diffusion anisotropy), mean diffusivity (MD -- average of the eigenvalues), axial diffusivity (AD -- largest eigenvalue), and radial diffusivity (RD -- third eigenvalue corresponding to diffusion perpendicular to the major eigenvector were derived ([@bb0065]). Quantitative maps were visually inspected for artifacts (i.e. slice intensity banding, FA hyper-intensities, distortions, and/or blurring).

To reduce subtle alignment inconsistencies that might result from not accounting for the repeated measurements ([@bb0050], [@bb0155]), a longitudinal registration pipeline was developed to align individual DTI measurements to a common template space. For each participant, an initial diffusion tensor template was created from all the acquired longitudinal time points using affine and diffeomorphic diffusion tensor registration, as implemented in DTI-TK ([@bb0640]). DTI-TK was then used to generate an overall, un-biased population-specific template from these subject-specific diffusion tensor templates. White matter tracts from the JHU ICBM-DTI-81 template ([@bb0450], [@bb0470]) were spatially aligned to this population template using the Advanced Normalization Tools diffeomorphic spatial registration ([@bb0055]) and nearest neighbor interpolation. The normalized JHU ICBM-DTI-81 template was warped into each subject\'s native space by applying the inverse of the spatial transformations estimated in the population- and subject-specific template generation step. A subset of 11 regions of interest (ROIs) reported to be implicated in ASD ([@bb0545]) were selected from the available 48 labels contained within the JHU template for subsequent analyses. These regions included: genu, body, and splenium of the corpus callosum; superior longitudinal fasciculus, internal capsules (anterior and posterior portions); corticospinal tract; uncinate fasciculus; cingulum; superior fronto-occipital fasciculus; and sagittal stratum (i.e. inferior longitudinal fasciculus and inferior fronto-occipital fasciculus). Left and right homologous pairs were additionally used where appropriate, for a total of 19 ROIs examined. For each longitudinal time point and anatomical region, the median FA, MD, AD, and RD values were extracted from each participant\'s corresponding native-space FA MD, AD, and RD maps, as the median is less sensitive to voxels with extreme values ([@bb1000]).

2.4. Calculating the Mahalanobis distance {#s0030}
-----------------------------------------

The Mahalanobis distance (D~M~; ([@bb0415])) is a multivariate extension of the Euclidean distance, measuring the distance of each member of a set of multivariate measures to the mean of their multivariate distribution. For each subject, D~M~ is calculated using the following formula:$$D_{M} = \sqrt{\left( {\overset{\rightarrow}{x} - \mu} \right)S^{- 1}\left( {\overset{\rightarrow}{x} - \mu} \right)^{T}}$$where $\overset{\rightarrow}{x}$ corresponds to the set of multivariate neuroimaging observations for each individual, *μ* is the mean of the multivariate distribution of neuroimaging measures, and *S* is the variance-covariance matrix between measures. For example, if *m* measures are collected from each individual, $\overset{\rightarrow}{x}$ and *μ* correspond to a 1 × *m* vector, *S* corresponds to an *m* × *m* matrix, and D~M~ from Eq. [(1)](#fo0005){ref-type="disp-formula"} is a scalar. In this way, D~M~ accounts for the variance of individual observations as well as the covariance between the set of observations, homologous to the Euclidean distance in univariate analysis. In the present study, we estimate D~M~ for individuals with ASD from their corresponding DTI brain measures, using the TDC as the population reference. In this case, D~M~ corresponds to how close an ASD individual\'s brain measures are to the multivariate mean of the TDC population, where larger D~M~ represents increased distance from the center of the typically developing population.

In constructing D~M~ from longitudinal measurements, it is important to account for neurodevelopmental processes ([@bb0155], [@bb0150], [@bb0365], [@bb0370], [@bb0530]). Generalized additive mixed models (GAMM\'s) were fit to the regional developmental trajectories of the DTI parameters (FA, MD, AD, and RD) of the TDC group to characterize the observed age-related white matter changes and establish a normative growth trajectory for each brain region. Generalized additive mixed models were utilized to characterize the age-related changes as these models have been designed specifically for cohort-sequential longitudinal designs ([@bb0610], [@bb0615]) and for their ability to account for repeated measurements from the same individual. Furthermore, since the growth model that describes white matter is unknown, the semi-parametric nature of these spline models provides flexibility in capturing subtle developmental changes compared to parametric growth models ([@bb0560]). Longitudinal modeling analyses were performed using R version 3.2.1 (R Development [@bb0540]), while accounting for the nuisance variables of head coil (due to upgrade discussed earlier) and total motion index.

Upon determining the best fit model of the TDC group, these models were used to predict FA, MD, AD and RD along the modeled TDC growth trajectory for every ASD participant at each time point and for each brain region. The difference between the participants\' parameter values from these predicted values (i.e. the model residuals) were calculated, corresponding to the vertical distance between the participant parameter measurements and the TDC reference growth trajectory. D~M~ for each time point was calculated from these residuals using eq. [(1)](#fo0005){ref-type="disp-formula"}, where $\overset{\rightarrow}{x} - \mu$ corresponds to the difference between observed measurements ($\overset{\rightarrow}{x}$) and modeled values (*μ*), and *S* is the variance-covariance matrix of the modeled residuals from the TDC group.

D~M~ was similarly calculated for each TDC individual. However, to avoid including an individual\'s measurements in the model fitting when establishing the reference growth trajectory, a leave-one-out approach was used when modeling regional FA, MD, AD and RD developmental trajectories. For a given TDC subject, FA, MD, AD, and RD longitudinal measurements were removed prior to modeling and participant-specific residuals and D~M~ was calculated as before. This process was repeated for each TDC participant.

After calculating D~M~ for each longitudinal time point, an average across these time points was computed for each participant, providing a single, representative D~M~ value for each individual. [Supplementary Fig. 1](#f0040){ref-type="graphic"} displays a representative schematic illustrating the process of calculating D~M~. Distributions of Mahalanobis distances were generated for both the ASD and TDC groups and the Bhattacharyya coefficient ([@bb0445]) was computed to assess the degree of overlap between the group distributions, where smaller Bhattacharyya coefficients correspond to a lesser degree of overlap. D~M~ was additionally calculated by considering regional DTI parameters (FA, MD, AD, and RD) separately.

2.5. Construction of univariate DTI distributions {#s0035}
-------------------------------------------------

Standard scores were similarly calculated for each ROI and DTI parameter (i.e. FA, MD, AD, RD). Longitudinal mixed effects models were used to characterize the age-related changes of the TDC group and establish a normative reference growth curve. Model residuals were calculated and normalized by the standard deviation of fit residuals. Standard scores for TDC participants were again calculated using a leave-one-out approach. Individual time points were aggregated by calculating the mean of individual time point standard scores, producing a single standard score for each individual. Distributions of regional standard scores were generated and again the Bhattacharyya coefficient was computed to measure distributional overlap.

3. Results {#s0040}
==========

Representative FA and MD trajectories for the ASD and TDC group are displayed in [Fig. 2](#f0010){ref-type="fig"} (AD and RD trajectories displayed in [Supplemental Fig. 2](#f0045){ref-type="graphic"}). These trajectories highlight the significant age-related changes of DTI parameters that occur across the first four decades of life as well as visually depict neurodevelopmental differences between the ASD and TDC groups. It can be appreciated that the age-related changes are non-linear, with rapid changes (i.e. increases in FA and decreases in MD, AD, and RD) occurring at early ages and slower changes occurring into adulthood. To characterize the overall shape of the TDC growth curve and establish a population reference, generalized additive mixed-effects models were used. These models depict the complexity of the TDC growth trajectory by smoothly bending to the data at important nonlinear growth spurts or declines.Fig. 2Developmental trajectories of white matter in ASD and TDC participants. Representative developmental trajectories of FA and MD from left hemispheric anterior limb of the internal capsule (*top*), right hemispheric superior longitudinal fasciculus (*middle*), and right hemispheric sagittal stratum (*bottom*). ASD (red) and TDC (blue) longitudinal observations are denoted by circles while dashed lines connect repeated time points for specific subjects. The solid blue line corresponds to the best fit generalized additive mixed-effects model, corresponding to the normative reference growth trajectory. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 2

3.1. Mahalanobis distances {#s0045}
--------------------------

Average D~M~ were computed for each ASD and TDC individual from the set of combined longitudinal regional brain FA, MD, AD, and RD measurements. The distribution of D~M~ across participants is shown in [Fig. 3](#f0015){ref-type="fig"}. It is evident that the ASD distribution of D~M~ values is shifted to the right and does not overlap with that of the TDC group, suggesting a larger mean and greater degree of microstructural deviation from the normative reference group. In comparing these group distributions, D~M~ values were found to be increased (*t(141)* = 27.911, p \< 0.001) and more variable (*F(91,56)* = 23.17, p \< 0.001) for the ASD individuals compared to the TDC participants. In particular, 92 of the 92 (100%) ASD participants had a D~M~ value greater than the TDC D~M~ mean (1.03), while 92 (%) had values greater than two standard deviations away from the TDC mean.Fig. 3Mahalanobis distance distributions of white matter. ASD (red) and TDC (blue) distributions of Mahalanobis distance (D~M~) calculated from combined FA, MD, AD and RD measurements. Representative normal curves for each group are overlaid onto these distributions to illustrate the rightward shift and increased variability of D~M~ values in ASD subjects. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 3

We additionally calculated D~M~ from the set of longitudinal FA and MD measures (i.e. removing AD and RD), as these are most commonly reported DTI measures in the literature. The distribution of D~M~ calculated from FA and MD is shown in [Fig. 4](#f0020){ref-type="fig"}. Similar to the previous results, the ASD distribution of D~M~ values is shifted to the right compared to the TDC group, suggesting a larger mean and greater degree of microstructural deviation from the normative reference group. In comparing these group distributions, D~M~ values were found to be increased (*t(141)* = 11.28, p \< 0.001) and more variable (*F(91,56)* = 6.91, p \< 0.001) for the ASD individuals compared to the TDC participants. In this case, 91 of the 92 (98.9%) ASD participants had a D~M~ value greater than the TDC D~M~ mean (1.55), while 65 (70.7%) had values greater than two standard deviations away from the TDC mean.Fig. 4Combined FA and MD Mahalanobis distance distribution. ASD (red) and TDC (blue) distributions of Mahalanobis distance (D~M~) calculated from combined FA and MD measurements. Representative normal curves for each group are overlaid onto these distributions to illustrate the rightward shift and increased variability of D~M~ values in ASD subjects. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 4

In addition, D~M~ was calculated separately for FA, MD, AD, and RD ([Fig. 5](#f0025){ref-type="fig"}a--d). Similar to D~M~ computed from combined DTI measurements, the distributions of D~M~ for each DTI parameter appear increased and more variable within the ASD group, suggesting each individual DTI parameter contributes to the microstructural deviations in ASD. In particular, the mean and standard deviations of the FA-, MD-, AD-, and RD-based ASD D~M~ distributions were found to be significantly different from the respective TDC distributions (FA-based D~M~: *t(141)* = 6.91, p \< 0.001; *F(91,56)* = 5.16, p \< 0.001; MD-based D~M~: *t(141)* = 6.01, p \< 0.001; *F(91,56)* = 5.22, p \< 0.001; AD-based D~M~: *t(141)* = 4.34, p \< 0.001; *F(91,56)* = 3.30, p \< 0.001; RD-based D~M~: *t(141)* = 6.01, p \< 0.001; *F(91,56)* = 5.22, p \< 0.001). With respect to the FA-based D~M~ values, 78 of 92 (84.8%) ASD individuals had scores greater than the TDC mean (2.08), and 35 of 92 (38.0%) had values greater than two standard deviations from the TDC mean. Similarly, 68 (73.9%) and 31 (33.7%) ASD individuals had MD-based D~M~ values greater than the TDC mean (1.81) and two standard deviations from the mean, respectively. For AD, 61 (66.3%) of ASD individuals had values greater than the TDC mean (2.02) and 22 (23.9%) had values greater than two standard deviations from the TDC mean, whereas 76 (82.6%) and 34 (40.9%) ASD individuals had RD-based D~M~ values greater than the TDC mean (1.63) and two standard deviations from the mean, respectively.Fig. 5FA, MD, AD, and RD Mahalanobis distance distributions. Mahalanobis distance (D~M~) distributions calculated from (A) FA measurements only, (B) MD measurements only, (C) AD measurements only, and (D) RD measurements only. ASD individuals are shown in red while TDC participants are shown in blue. Representative normal curves for each group are overlaid onto these distributions to illustrate the rightward shift and increased variability of D~M~ values in ASD subjects. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 5

The distributions of D~M~ computed using all the DTI parameters between the ASD and TDC individuals were completely disjoint and therefore yielded a Bhattacharyya coefficient of zero. The next smallest Bhattacharyya coefficient was for the combined FA and MD coefficients (8.60), followed by RD-based D~M~ values (13.96), AD-based D~M~ values (15.81), FA-based D~M~ values (16.03), and finally the MD-based D~M~ values (16.09). This indicates that ASD and TDC distributions of D~M~ values have the greatest separation when calculated from each of the DTI parameters, suggesting each parameter is informative for assessing microstructural brain deviations of ASD.

3.2. Univariate DTI distributions {#s0050}
---------------------------------

We further compared the distribution of D~M~ values to univariate distributions of FA, MD, AD, and RD standard scores. Representative univariate distributions of the DTI parameters are shown in [Fig. 6](#f0030){ref-type="fig"}. To make these univariate measures comparable to D~M~ values, the absolute value of the standard score was taken. In most brain regions, standard scores are larger within the ASD group, suggesting larger FA, MD, AD, and RD deviations from the normative growth curve. [Table 2](#t0010){ref-type="table"} provides details for both the ASD and TDC group mean differences of these univariate distributions as well as whether the variability of these distributions differed. Of the examined brain regions, FA and RD of the body of the corpus callosum and AD and MD of the left posterior limb of the internal capsule had the largest group difference, while FA and RD in the genu of the corpus callosum, MD in the left superior fronto-occipital fasciculus, and AD in the left uncinate fasciculus had the least overlap between univariate standard score distributions. Comparing univariate Bhattacharyya coefficients to the Bhattacharyya coefficients derived from the D~M~ distributions highlights that D~M~ measures have less overlap (i.e. greater delineation) between ASD and TDC individuals than univariate-based measures.Fig. 6Standard score distributions of white matter. Representative FA, MD, AD, and RD distributions of univariate standard scores from the genu of the corpus callosum (*top*), right hemispheric superior fronto-occipital fasciculus (*middle*), and left hemispheric cingulum (*bottom*). Compared to distributions of D~M~, univariate distributions are less variable between ASD and TDC individuals.Fig. 6Table 2Comparison of standard score distributions between ASD and TDC groups. Differences between the group distribution means for each DTI parameter were assessed using t-statistics, while the differences in the variability of the distributions of DTI parameters were tested using F-statistics. Bhattacharyya coefficients were used to assess the overlap between ASD and TDC distributions.Table 2RegionFAMDADRD*t(141)*p*F(91,56)*pB. Coeff*t(141)*p*F(91,56)*pB. Coeff*t(141)*p*F(91,56)*pB. Coeff*t(141)*p*F(91,56)*pB. CoeffGenu of corpus callosum3.10\< 0.0011.910.0122.471.050.301.400.1725.361.920.061.370.2025.422.450.021.430.1522.29Body of corpus callosum3.97\< 0.0012.94\< 0.00122.742.600.013.23\< 0.00125.020.270.781.030.9326.403.81\< 0.0013.67\< 0.00122.78Splenium of corpus callosum2.210.032.86\< 0.00123.662.220.032.41\< 0.00125.20− 0.190.850.980.9226.813.48\< 0.0013.94\< 0.00122.58Right anterior limb of internal capsule1.000.321.540.0825.920.260.791.290.3026.830.650.521.150.5825.793.38\< 0.0011.300.2925.26Left anterior limb of internal capsule0.650.521.140.6026.551.390.171.160.5624.000.610.540.840.4527.331.070.281.290.3125.24Right posterior limb of internal capsule0.870.380.600.0325.752.600.011.380.2026.59− 0.750.461.350.2226.872.200.031.430.1525.79Left posterior limb of internal capsule− 0.540.590.570.0226.192.750.011.790.0226.720.340.741.030.9325.851.010.321.220.4227.59Right superior longitudinal fasciculus1.990.051.940.0124.310.730.471.390.1925.510.170.871.500.1026.531.020.311.680.0424.58Left superior longitudinal fasciculus1.500.141.620.0524.430.840.401.370.2025.98− 0.540.591.030.9226.551.810.071.880.0124.78Right corticospinal tract− 0.900.370.970.8827.89− 0.890.381.390.1827.820.070.940.650.0727.64− 0.940.350.920.7228.86Left corticospinal tract1.170.241.390.1825.02− 0.500.621.470.1228.11− 2.430.020.640.0626.660.820.410.850.4926.59Right uncinate fasciculus0.420.681.140.6026.682.720.010.970.8727.171.680.101.050.8726.941.710.091.110.6926.80Left uncinate fasciculus0.310.751.070.7926.120.400.691.010.9726.421.480.140.770.2624.49− 0.470.640.590.0325.85Right cingulum− 0.040.971.470.1225.20− 1.360.180.710.1427.640.630.531.450.1324.700.990.321.510.1024.70Left cingulum0.710.482.73\< 0.00125.340.500.610.950.8126.50− 0.020.981.150.5827.421.120.271.470.1225.81Right superior fronto-occipital fasciculus0.700.481.570.0726.501.880.061.350.2224.98− 0.220.832.51\< 0.00127.552.140.032.37\< 0.00125.14Left superior fronto-occipital fasciculus0.850.401.660.0427.022.100.041.530.0923.902.160.033.61\< 0.00126.121.050.291.040.8825.71Right sagittal stratum1.290.201.230.4026.851.340.181.930.0127.71− 0.720.470.880.5728.301.850.072.40\< 0.00126.80Left sagittal stratum2.030.041.250.3624.742.480.012.28\< 0.00125.98− 1.070.290.660.0727.392.630.011.760.0224.41

3.3. Associations with sample characteristics {#s0055}
---------------------------------------------

To investigate whether microstructural differences corresponded to phenotypic characteristics of the sample, correlations between D~M~ and full-scale IQ, verbal IQ, performance IQ and the Social Responsiveness Scale total raw score were computed. Scatter plots depicting these correlations are shown in [Fig. 7](#f0035){ref-type="fig"}. Correlations between D~M~ and IQ characteristics were not observed to be significant in control participants, however, a negative relationship between SRS total raw score and D~M~ was observed (r = − 0.29, p = 0.04). In autism participants, increased D~M~ was significantly associated with lower full-scale IQ (r = − 0.28, p = 0.01), lower performance IQ (r = − 0.27, p = 0.01), and lower verbal IQ (r = − 0.21, p = 0.05). SRS total raw score showed a positive relationship with D~M~ (increased autism severity were associated with increased deviation from normal); however, this also did not reach statistical significance (r = 0.12, p = 0.27).Fig. 7Associations of Mahalanobis distance with phenotypic characteristics. Scatter plots of the relationships between D~M~ and full-scale IQ (A), verbal IQ (B), performance IQ (C), and SRS total raw scores (D). Correlations within the ASD group (*left panel*) were found to be significant between D~M~ and full-scale, verbal and performance IQ. Correlations with IQ were not observed to be significant in the TDC participants (*right panel*). In the ASD group, a positive trend between SRS total raw and D~M~ was observed, however this association was not significant. Please note the ordinate axis scale differences between ASD and TDC scatter plots.Fig. 7

4. Discussion {#s0060}
=============

In this work, we have used the Mahalanobis distance (D~M~) as a metric to characterize complex and subtle relationships of multivariate measures of individual brain microstructure within a longitudinal sample of individuals with autism spectrum disorder. We show that D~M~ formed from DTI measures of FA, MD, AD, and RD across regions of white matter provides the greatest separation between ASD and TDC groups compared to univariate measures and to D~M~ computed from these parameters separately. These results substantiate that ASD impacts not only a single brain region or white matter tract, but rather that ASD affects multiple brain regions, re-confirming that it is a heterogeneous neurodevelopmental disorder. Furthermore, our findings suggest that D~M~ may be effective at characterizing the degree of brain differences within individuals with ASD as well as informing the microstructural heterogeneity and phenotypic characteristics of individuals.

Evaluation of the degree to which an individual deviates from a normative reference is informative for assessing brain differences and shifting from analyses focused on group-based differences to measures aimed at characterizing individual differences. Standardized scores of head circumference, brain volume, and other brain features have been routinely used to assess the distribution of brain characteristics in individuals with ASD ([@bb0060], [@bb0135], [@bb0260], [@bb0340], [@bb0345], [@bb0435], [@bb0490]), as well as other disorders, including mild traumatic brain injury ([@bb0310], [@bb0400]), bipolar disorder ([@bb0285]), multiple sclerosis ([@bb0485]), and Alzheimer\'s disease ([@bb0420]), among others. However, as it becomes commonplace to acquire multi-modal information from study participants, it becomes necessary to account for the multidimensional aspects of data. D~M~ provides a direct multivariate extension of a common univariate score, while, importantly, accounting for the variance of each variable and covariance between variables. This is essential given that neuroimaging measures can have different scales and be inherently correlated within and between different imaging modalities ([@bb0235], [@bb0320]). Hence, while the current study has presented D~M~ in ASD, this measure may be informative to assess individual brain differences in a broader range of disorders, including mild traumatic brain injury, bipolar disorder, and Alzheimer\'s disease.

To our knowledge, the current study is the first to use the Mahalanobis distance to evaluate brain variation in ASD. Recently, [@bb0320] used D~M~ to combine complementary measures of white matter to examine the brain development in healthy infants and found that D~M~ captured maturational relationships more reliably than univariate measures ([@bb0320]). D~M~ has additionally been used to differentiate individuals with Alzheimer\'s disease and mild cognitive impairment ([@bb0395]) and distinguish individuals with schizophrenia from healthy controls ([@bb0100]). Similarly, our findings suggest that multivariate approaches may be advantageous for describing individual brain deviations in ASD compared to univariate techniques. These results are consistent with other recent efforts that have utilized alternative multivariate analysis strategies in the study of ASD (for a review, see ([@bb0380])). For example, support vector machines and other machine learning strategies have demonstrated the ability to accurately distinguish individuals with ASD from typically developing controls using a variety of neuroimaging measures as well as identify salient brain regions and networks that are implicated in core behavioral and social deficits ([@bb0185], [@bb0280], [@bb0295], [@bb0350], [@bb0570], [@bb0590]). Taken together, this corpus of research suggests that these analysis strategies improve our ability disentangle complementary information provided by multivariate brain measures and thus better characterize the anatomical, functional, and microstructural heterogeneity of ASD. This is essential for being able to identify possible ASD subgroups or specific individuals with unique brain features that are significantly different from both unaffected controls and peers with ASD.

Neuroimaging studies have provided great insight into the neurobiological changes that occur in ASD and have provided extensive evidence of widespread brain alterations that take place over the lifespan (for a review see [@bb0025], [@bb0180], [@bb0545]). However, while many of these studies have highlighted the complexity of these brain differences, where numerous regions and networks across the brain are involved, these brain regions and networks have typically been studied separately. Such approaches are instructive to understand the role of each particular brain region or network; however, the diversity of neuroimaging findings continues to suggest that a specific disparity may not be experienced by all individuals with ASD. Indeed, in comparing white matter regions between ASD and TDC groups, we observed differences across white matter in both the group mean and variance of the standard score distributions of DTI parameters (i.e. FA, MD, AD, and RD), particularly in the corpus callosum (genu and body), superior longitudinal fasciculi, and superior fronto-occipital fasciculi. Nevertheless, by combining regional measures of white matter microstructure across the brain to form D~M~, we are able to leverage the multivariate information from each of these brain regions to calculate a measure that describes the degree to which these collective brain measures differ from a normative reference.

In addition to D~M~ providing a measure of brain deviation, examination of the distributions of D~M~ ([Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}) and regional standardized scores ([Fig. 6](#f0030){ref-type="fig"}) across individuals provided insights into the microstructural heterogeneity of ASD. In particular, the variance of D~M~ distributions were found to be significantly increased, while this increased variation was observed in only a small proportion of univariate distributions. Increased variation has similarly been reported throughout studies of autism ([@bb0015], [@bb0330], [@bb0350], [@bb0435], [@bb0490], [@bb0560]), which suggests brain alterations do not necessarily impact specific brain regions in the same way, but rather have a varied impact across individuals with ASD. The use of multivariate techniques is, therefore, advantageous over other approaches, such as the use of signal histograms and univariate distributions, as they enable a broader characterization of underlying alterations. Furthermore, unlike signal histograms, D~M~ can incorporate multiple image contrasts that provide an additional dimension of capturing brain alteration. The ability to identify and characterize the heterogeneous alterations observed in ASD, as presented in the current study, is thus an important aspect for both identifying and understanding specific neurobiological mechanisms of autism.

For individuals with autism, we found that increased D~M~ (i.e. increased brain deviation) was associated with decreased full-scale, performance, and verbal IQ\'s. However, while the relationship between SRS total raw scores and D~M~ was positive, the correlations were not observed to be significant. Consistent with our results, other studies have found connections between microstructural neuroimaging indices and phenotypic and symptomology measures ([@bb0015], [@bb0465], [@bb0550]). These associations are particularly informative in identifying neural mechanisms as these measures are consistently used to assess core diagnostic and phenotypic characteristics in autism. In all, this collective body of research indicates a link between underlying white matter microstructure and ASD symptomology and severity.

Despite our findings suggesting widespread white matter microstructural differences in ASD, D~M~ does not provide information into which specific microstructural feature(s) drives the observed individual difference. For example, one individual may be observed to have an abnormal corpus callosum microstructure while having a normal appearing anterior internal capsule. Another individual may have a deviant anterior internal capsule microstructure, but appear to have a normative corpus callosum. Even still, another individual may have a differential developmental trajectory in both of these regions. Yet, the D~M~ for each of these cases could be identical. As observed in the current study, including multiple DTI parameters may increase the separability of the ASD and TDC distributions, which suggests that each of these measures uniquely contribute to D~M~. However, D~M~ provides an omnibus measure of individual brain difference and therefore interpretation of the specific microstructural characteristics or processes resulting in the observed difference, such as a difference in the developmental trajectory, is limited. The use of decomposition methods, such as principal component analysis (PCA), could be used in combination with D~M~ to identify the underlying brain feature(s) that are subsequently altered. Furthermore, while measures derived from DTI (i.e. FA and MD) are sensitive to underlying changes of white matter, these parameters lack specificity to underlying microstructural changes ([@bb0010], [@bb0070], [@bb0290]). Incorporating additional measures, such as head circumference ([@bb0135], [@bb0340], [@bb0345]), volumetric measurements ([@bb0085], [@bb0425]), indices of cortical thickness ([@bb0645]) and functional connectivity ([@bb0045], [@bb0120]) as well as other white matter markers ([@bb0010], [@bb0160], [@bb0170], [@bb0635]) will likely alter the covariance between parameters and alter the values of D~M~. This may help to improve the interpretation of brain differences observed in ASD as well as provide further improvements in discriminating between ASD and TDC individuals.

In addition to understanding the macrostructural and microstructural characteristics of the brain that may be disrupted in ASD, converging evidence points to altered brain development as having a fundamental role ([@bb0130], [@bb0335], [@bb0360], [@bb0385], [@bb0560], [@bb0605]). The human brain undergoes great changes over the course of the lifespan ([@bb0105], [@bb0145], [@bb0155], [@bb0165], [@bb0195], [@bb0215], [@bb0220], [@bb0355], [@bb0365]), while such developmental processes have a critical role in establishing both structural and functional brain networks that ultimately enable the processing of complex information ([@bb0175]). Here, generalized additive mixed effects models were used to characterize longitudinal developmental trajectories of the examined white matter regions, allowing us to account for nonlinear neurodevelopmental changes across our sample and enabling a direct comparison of groups and individuals of all ages. However, while the variability of brain imaging measures beyond the average growth trajectory may change with age, individual brain deviations at one age may differ at another age. While in the current study we averaged across the longitudinal time points to establish an overall individual measure of deviation, future studies may examine the changes of D~M~ with age. Indeed, D~M~ has been used to depict the development of white matter in healthy infants ([@bb0320]), and thus such future studies investigating the age-relationships of D~M~ in ASD may provide important insights about the timing of abnormal brain deviations in ASD and help identify when such brain changes first begin to appear.

While the presented study provides strong evidence of D~M~ as an informative measure of individual brain deviation, there are several limitations to this study. First, the formation D~M~ relies on the assumption that the TDC growth trajectory can be used as a normative reference for the examined sample. Although typical development was confirmed using extensive neuropsychological assessments and detailed medical history information, it is possible that some participants may later develop atypically and thus not be representative of a normal population. Similarly, we presumed that the smoothed splines of the generalized additive mixed effects models used herein provided a characteristic representation of the typically developing growth trajectory. While these models have been shown to effectively model growth trajectories in the corpus callosum ([@bb0560]), additional models have been used to characterize the developmental trajectories of DTI ([@bb0365], [@bb0505]) and other imaging parameters ([@bb0150], [@bb0515], [@bb0645]). Future studies comparing growth models that describe the neurodevelopmental trajectories are therefore needed to determine the best current models of brain development in ASD. Lastly, D~M~ provides limited interpretability beyond being able to characterize the magnitude of deviation. For example, it may be informative to identify whether certain ASD brain regions are abnormally enlarged or reduced compared to that of typically developing individuals. Incorporating measures of D~M~ with multivariate classification techniques ([@bb0185], [@bb0350], [@bb0570]) may help determine the relative weighting that each brain region contributes to the overall distance measure.

5. Conclusion {#s0065}
=============

Heterogeneity of brain-based descriptors is a fundamental feature of ASD that makes identification of neuroimaging-based phenotypes challenging. However, multivariate measures, such as the Mahalanobis distance, are able to incorporate this inherent heterogeneity and provide an informative descriptor about an individual\'s overall deviation from a representative reference sample. In particular, the results from the present study suggest that the Mahalanobis distance formed from multiple measures of white matter microstructure can provide an increased degree of separation between individuals with and without autism, compared to more commonly used univariate approaches. In particular, these results suggest that the Mahalanobis distance of brain features may provide a novel measure that may be informative to identify autism sub-groups or severely-impaired individuals with autism. This has particular value for future studies evaluating genetic and environmental risk factors that are associated with specific neurobiological mechanisms of autism.

The following are the supplementary data related to this article.Supplementary Fig. 1Illustrative schematic of Mahalanobis distance (DM) calculation. First, the normative models of each brain region are constructed from the neuroimaging data of the typically developing controls. The model residuals from these models are used to construct the covariance matrix, S. Using these normative models, the difference between the model and observed neuroimaging measure for each brain region is calculated and used to compute DM.Supplementary Fig. 1Supplementary Fig. 2Developmental trajectories of white matter in ASD and TDC participants. Representative developmental trajectories of AD and RD from left hemispheric anterior limb of the internal capsule (*top*), right hemispheric superior longitudinal fasciculus (*middle*), and right hemispheric sagittal stratum (*bottom*). ASD (blue) and TDC (black) longitudinal observations are denoted by circles while dashed lines connect repeated time points for specific subjects. Solid black line corresponds to the best fit generalized additive mixed-effects model, corresponding to the normative reference growth trajectory.Supplementary Fig. 2
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